European Addiction Research
European Addiction Research is a peer-reviewed medical journal that focuses on the study and treatment of addiction. The journal publishes original research, review articles, and clinical studies related to the field of addiction.
Overview[edit | edit source]
The European Addiction Research journal was established in 1995. It is published by Karger Publishers, a Swiss-based international publishing company specializing in medical and scientific literature. The journal's editor-in-chief is Gerhard Bühringer, a renowned addiction researcher from the Technical University of Dresden, Germany.
The journal covers a wide range of topics related to addiction, including neurobiology, psychopathology, epidemiology, clinical practice, and public health. It aims to provide a platform for researchers, clinicians, and policymakers to share and discuss the latest findings and developments in the field of addiction.
Content[edit | edit source]
The content of the European Addiction Research journal is diverse and comprehensive. It includes original research articles that report the latest findings in addiction research, review articles that summarize and analyze the current state of knowledge on specific topics, and clinical studies that report the results of trials and other clinical research.
The journal also publishes special issues on specific topics, such as the neuroscience of addiction, substance abuse and mental health, and public policy and addiction. These special issues are often guest-edited by leading experts in the field.
Impact[edit | edit source]
The European Addiction Research journal has a significant impact on the field of addiction research. According to the Journal Citation Reports, the journal has an impact factor of 2.674, ranking it 26th out of 140 journals in the category of "Substance Abuse" in 2019.
See also[edit | edit source]
References[edit | edit source]
 | This medical article is a stub. You can help WikiMD by expanding it. |
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
